Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in ambulant boys with Duchenne muscular dystrophy
2012-002566-12Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Oct 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of givinostat in Duchenne muscular dystrophy (DMD), sponsored by Italfarmaco. Primary endpoint: Change in muscle fiber area percentage. Started Oct 2012; status: completed.
02
Drugs
givinostat
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2012-002566-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002566-12.